Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

eBusiness Institute and Lingaro combine forces to deliver first-class digital solutions

Geneva, December 15, 2021 - Geneva-based eBusiness Institute today announces its acquisition by global data and analytics company, Lingaro Group. This powerful union, shaking up the already competitive landscape of digital consulting companies, will set new standards for delivering first-class end-to-end digital transformation solutions built around insights from factual data and analytics.According to Gartner’s 2021 research, more than 80% of marketing executives are disappointed with their current innovation implementation status. They lack the technology and digital marketing expertise

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them in Penneo A/S

Company Announcement No. 30-2021Copenhagen, 15 December 2021 In accordance with the Market Abuse Regulation, Penneo must notify Finanstilsynet and publicly disclose transactions made by persons discharging managerial responsibilities and persons closely associated with them on trading of Penneo shares. Penneo hereby notify and submit the following transaction of shares in Penneo: Name: André Clément Holding ApSTitle: Legal person closely associated with André Clément (Chief Commercial Officer of

CELLINK and Nanoscribe join forces to launch the Quantum X bio, the world’s most accurate 3D bioprinter

The Quantum X bio combines CELLINK’s bioprinting expertise with the engineering excellence of Nanoscribe to create a first-of-Its-kind bioprinter Today, BICO companies CELLINK and Nanoscribe announced the launch of the Quantum X bio, a revolutionary printing platform providing researchers with first-of-its-kind submicron bioprinting resolution. Powered by Two Photon Polymerization (2PP), the Quantum X bio is the premier tool for miniaturizing bioprinting, redefining what it means to work within advanced biomedical applications, including tissue engineering and regenerative medicine.

BioStock: Abliva on the IND-approval from FDA

A few weeks ago, the US Food and Drug Administration approved Abliva’s Investigational New Drug application for KL1333, enabling the start of a registrational phase II/III study with first patients due to be recruited in 2022. BioStock reached out to Magnus Hansson, CMO & VP Preclinical and Clinical Development, for a comment.Read the interview with Magnus Hansson at biostock.se: https://www.biostock.se/en/2021/12/abliva-on-the-ind-approval-from-fda/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

To the moon and beyond – SSC takes years of lunar experience into the future

The moon has been a focal point for the space industry since the 1950’s. Early on, SSC joined the lunar race and the company has gathered extensive experience as the world’s first commercial lunar communications service. Now, SSC is preparing for future lunar missions in the coming years, supporting commercial missions to the moon, including for Astrobotic, Masten Space Systems and Firefly Aerospace in the U.S. “With the lunar legacy that lies within this company, dating all the way back to the Apollo program, we are confident to take on the future of lunar and deep-space missions. Our

Preliminary assessment of received acceptances in Murgröna Holding’s public offer to the shareholders of ICA Gruppen

THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO ANY JURISDICTION (INCLUDING WITHOUT LIMITATION AUSTRALIA, CANADA, CHINA, HONG KONG, JAPAN, MEXICO, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR SWITZERLAND) WHERE THE DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE IN CONFLICT WITH ANY APPLICABLE LAWS OR REGULATIONS. THE OFFER IS NOT BEING MADE TO (AND ACCEPTANCE FORMS WILL NOT BE ACCEPTED FROM OR ON BEHALF OF) PERSONS WHOSE PARTICIPATION IN THE OFFER WOULD REQUIRE THAT ANY OFFER DOCUMENTS ARE PREPARED, FILINGS ARE EFFECTUATED OR OTHER MEASURES

Dignitana publishes December newsletter

Dignitana AB today publishes the December newsletter highlighting progress with reimbursement, increased awareness through media coverage, and new locations in the U.S. To read the newsletter click here  or visit Dignitana.com .The Dignitana InBrief newsletter is published monthly and posted at www.dignitana.com as part of Dignitana's commitment to provide ongoing communication to the market. To receive future Dignitana news directly to your email, subscribe here 

BioStock: Stayble Therapeutics strengthened in 2021

In 2021, Stayble Therapeutics made progress in the development of a disease-modifying injection treatment for chronic discogenic low back pain. During the year, Stayble Therapeutics was strengthened with the recruitment of several key persons and an oversubscribed share issue. Finally, they were able to present positive interim results from the phase IIb study with STA363. BioStock contacted CEO Andreas Gerward to get his thoughts on the past year and what to expect next.Read the interview with Stayble Therapeutics' CEO Andreas Gerward at biostock.se: https://www.biostock.se/en/2021/12/

Mandatory notification of trade

On December 14[th] 2021, DNB has, on behalf of Otello Corporation, purchased 740 shares for use in the group's employee share purchase plan (ESPP). The shares have been acquired at a price of NOK 27.00. The discounted share price to the employees is NOK 21.60 per share. The following primary insiders have purchased shares: Scott Andrew Kerrison purchased 740 shares at NOK 21.60. As of today the primary insider holds 740 shares in the Company.

Realheart's artificial heart becomes 10-20 percent smaller

Realheart is developing the world's first four-chamber artificial heart. Now the company's design team has identified an opportunity to make the heart 10-20 percent smaller in size, which could have a major impact on future patients and on Realheart's future market.Realheart's research and development work is conducted in three legs: digitally, in the laboratory, and through anatomical and animal studies, all of which are progressing in parallel. During this autumn's animal studies, the pump was again confirmed to work well. At the same time, the design team discovered in laboratory

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 14th December 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,581,770 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Safello Adds Polygon and Polkadot to Its Cryptocurrency Offering

Stockholm, 15 December 2021 | Swedish fintech Safello  today announced it is expanding its support for cryptocurrencies to include Polygon and Polkadot. The news comes shortly after the successful launch of Chainlink that showed a spike in interest. Safello now offers five currencies: Bitcoin (BTC), Ethereum (ETH), Chainlink (LINK), Polygon (MATIC) and Polkadot (DOT). Safello is currently the only Swedish crypto company to offer direct investment in Polygon and Polkadot. Furthermore, Safello is the only Sweden based entry point to Polygon as the currency is not

Truecaller increases focus and investments in the iPhone product through a fully redesigned interface

Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is pleased to announce the roll-out of a completely new design of Truecaller for iPhone. The new interface is simplified, easy to use and enhances the search engine function that is used by millions of Truecaller users on iPhone every day. The recent enhancement is the first step in a bigger initiative to provide the best user experience on iPhone for consumers and enterprises.“We put a lot of emphasis on improving the experience of Truecaller on iPhone with our increased, long-term focus on

BioStock: Spago Nanomedical prepares for an eventful 2022

Lund-based Spago Nanomedical has completed the pre-clinical programme with SN201, the candidate drug in the cancer treatment project Tumorad. Reaching this milestone,together with the completion of the second cohort in the SPAGOPIX-01 study, the company ends the year on a high note as it prepares for an eventful 2022. BioStock reached out to CEO Mats Hansen to find out more.Read the interview with Spago Nanomedical's CEO Mats Hansen at biostock.se: https://www.biostock.se/en/2021/12/spago-nanomedical-prepares-for-an-eventful-2022/ This is a press release from BioStock - Connecting

Brain+ lands first large-pharma partnership deal to enter the German market for dementia products

BRAIN+ A/S (BRAINP) Company Announcement No. 4-2021 Wednesday, December 15, 2021, 8:20 CET The information communicated in this announcement is “inside information” for the purposes of article 7 of the Market Abuse Regulation 596/2014 Brain+ has signed a partnership agreement with RoX Health , a subsidiary of the global pharma company Roche in Germany, to bring its first dementia products to the German market.Germany is the largest and most interesting EU market to Brain+: More than 1.5 million people are living with dementia in Germany. With new and

Help with your Swedish tax returns—how to calculate the acquisition cost for Sectra redemption shares 2021

Linköping, Sweden, December 15, 2021 – The Annual General Meeting of the international medical imaging IT and cybersecurity company Sectra  (STO: SECT B) resolved to carry out a redemption program according to which SEK 0.90 per share was distributed to Sectra shareholders in November 2021. According to the general advice issued by the Swedish Tax Agency regarding the redemption program, 99.5% of the acquisition cost for an original Class A or Class B share in Sectra AB should be attributed to remaining shares and 0.5% to redemption shares of the respective class.

Arctic Paper prepares for 17 MW solar power plant in Kostrzyn

Arctic Paper Group has concluded contracts with the Polish company MAZEL SA to support the Group in preparation of documentation and obtaining necessary permits to start building solar power plant with a capacity of 17 MW. The start-up of building is planned for September 2022.The investment is an important step in the implementation of Arctic Paper Group´s new 4P Strategy for 2030, under which, in addition to graphic paper and cellulose, the Group will develop in the packaging and energy segments.  “The experiences from our pilot installation are positive, now we are ready to take the

Pivotal AUR87A study of GAGome-based liquid biopsy for kidney cancer recurrence opens 26th site

Stockholm, Dec 15, 2021: Swedish molecular diagnostics company Elypta announces today the activation of the 26th recruiting site for the AURORAX-0087A (AUR87A) study, making it the largest diagnostics study ever of the most common type of kidney cancer. AUR87A is intended to validate Elypta’s metabolism-based liquid biopsy platform for the detection of recurrence after surgery in clear cell renal cell carcinoma (ccRCC).About 1 in 5 ccRCC patients experience recurrence within 5 years after surgery for confirmed disease. Since there is no liquid biomarker yet approved for ccRCC recurrence,

Proposals of Glaston Corporation’s Shareholders’ Nomination Board to the Annual General Meeting 2022

Glaston Corporation                       Stock Exchange Release                                  15.12.2021 at 9.15Proposal for the composition of the Board of DirectorsThe Nomination Board of Glaston Corporation proposes to the Annual General Meeting, due to be held on 12 April 2022, that the number of members of the Board of Directors shall be seven (7) until closing of the Annual General Meeting 2023, and that the current members of the Board of Directors Sebastian Bondestam, Antti Kaunonen, Sarlotta Narjus, Veli-Matti Reinikkala, Arja Talma, Tero Telaranta and Michael Willome shall

DECLARATION OF PURCHASE OPTION

Höegh Beijing is a car carrier built in 2010 and employed on a charter to Höegh Autoliners Shipping AS (“Höegh Autoliners”) until June 2022. In the contract, Höegh Autoliners has an option to purchase the vessel at the end of the charter period, which has now been declared. The effective purchase date is 20th June 2022 with a purchase price of USD 22 million. Ocean Yield ASA will receive net cash proceeds after repayment of debt related to the vessel of about USD 12 million. The intention is to reinvest the net cash proceeds into new vessels with long-term charters.

Preclinical data confirm the unique specificity and disease-modifying potential of Alzinova’s monoclonal antibody, ALZ-201

Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company developing treatments of Alzheimer’s disease by specifically targeting neurotoxic amyloid-β (Aβ) oligomers, today announces that a research project evaluating Alzinova’s monoclonal antibody, ALZ-201, has been successfully completed in collaboration with Amsterdam University Medical Centers. Data from the project confirm the unique specificity and preclinical efficacy of ALZ-201 and the related clinical-stage vaccine ALZ-101.The collaborative project evaluated Alzinova’s monoclonal antibody, ALZ-201, as a potential novel therapy

Momentum Group AB completes change of registered name to Alligo AB

Former Momentum Group AB (publ) (the “Company”) has completed the change of registered name to Alligo AB, which was voted in favor for at the Extraordinary General Meeting held on 2 December 2021.The Company is still listed on Nasdaq Stockholm, now by the name Alligo AB, and with the new ticker ALLIGO B. The Company has also launched a new website and graphic profile, please refer to https://www.alligo.com/. The change of registered name is part of the preparations for a separate listing of the business area Components & Services on Nasdaq Stockholm through a listing of the subsidiary

There are no items matching the current filter
There are no more items matching the current filter
Back to top